N
HZNP

Nuveen’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Nuveen’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-849,393
Closed -$98.3M – 3408
2023
Q3 		$98.3M Sell
849,393
-496,973
-37% -$53.4M 0.03% 372
2023
Q2 		$138M Sell
1,346,366
-390,592
-22% -$41.2M 0.05% 308
2023
Q1 		$190M Sell
1,736,958
-2,921,685
-63% -$323M 0.07% 238
2022
Q4 		$530M Sell
4,658,643
-2,295,927
-33% -$191M 0.21% 110
2022
Q3 		$430M Sell
6,954,570
-41,263
-0.6% -$2.88M 0.17% 116
2022
Q2 		$558M Buy
6,995,833
+317,874
+5% +$30.1M 0.22% 101
2022
Q1 		$726M Sell
6,677,959
-367,464
-5% -$35.8M 0.24% 89
2021
Q4 		$759M Buy
7,045,423
+171,736
+2% +$18.7M 0.22% 96
2021
Q3 		$753M Buy
6,873,687
+2,038,214
+42% +$212M 0.23% 91
2021
Q2 		$453M Buy
4,835,473
+1,101,710
+30% +$101M 0.14% 144
2021
Q1 		$344M Buy
3,733,763
+523,312
+16% +$44.2M 0.11% 176
2020
Q4 		$235M Sell
3,210,451
-35,685
-1% -$2.65M 0.08% 221
2020
Q3 		$252M Buy
3,246,136
+629,552
+24% +$43.3M 0.1% 193
2020
Q2 		$145M Buy
2,616,584
+494,796
+23% +$21.2M 0.06% 277
2020
Q1 		$62.8M Sell
2,121,788
-768,123
-27% -$26M 0.03% 424
2019
Q4 		$105M Sell
2,889,911
-63,978
-2% -$1.96M 0.04% 401
2019
Q3 		$80.4M Buy
2,953,889
+1,281,050
+77% +$33.1M 0.03% 470
2019
Q2 		$40.2M Buy
1,672,839
+1,589,614
+1,910% +$40.3M 0.02% 793
2019
Q1 		$2.2M Sell
83,225
-31,577
-28% -$748K 0.01% 630
2018
Q4 		$2.24M Sell
114,802
-18,952
-14% -$371K 0.01% 606
2018
Q3 		$2.62M Sell
133,754
-40,123
-23% -$763K 0.01% 616
2018
Q2 		$2.88M Sell
173,877
-11,807
-6% -$180K 0.02% 562
2018
Q1 		$2.64M Buy
185,684
+57,078
+44% +$843K 0.02% 576
2017
Q4 		$1.88M Buy
128,606
+258
+0.2% +$3.62K 0.01% 615
2017
Q3 		$1.63M Buy
128,348
+19,354
+18% +$246K 0.01% 647
2017
Q2 		$1.29M Buy
108,994
+26,111
+32% +$325K 0.01% 694
2017
Q1 		$1.23M Buy
82,883
+54,985
+197% +$891K 0.01% 883
2016
Q4 		$451K Buy
27,898
+17,221
+161% +$312K ﹤0.01% 1334
2016
Q3 		$194K Hold
10,677
– – ﹤0.01% 1342
2016
Q2 		$176K Buy
+10,677
New +$173K ﹤0.01% 1261

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nuveen's HZNP Position: Q4 2023 in Review

Nuveen sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 849,393 shares — an estimated $98.3M sold.

Nuveen first reported a position in HZNP in Q2 2016 and held it in 30 quarters. The position peaked at $759M in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Nuveen reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Nuveen sold 849,393 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $98.3M.
  • Nuveen first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2016 and held it in 30 quarters.
  • Nuveen's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $759M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.